Show simple item record

Authordc.contributor.authorSoto, Abel A.
Authordc.contributor.authorOrtiz, Gerardo
Authordc.contributor.authorContreras, Sofía
Authordc.contributor.authorSoto Rifo, Ricardo Andrés
Authordc.contributor.authorGonzález, Pablo A.
Admission datedc.date.accessioned2022-12-20T17:31:26Z
Available datedc.date.available2022-12-20T17:31:26Z
Publication datedc.date.issued2022
Cita de ítemdc.identifier.citationMicroorganisms 2022, 10, 1754es_ES
Identifierdc.identifier.other10.3390/microorganisms10091754
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/189875
Abstractdc.description.abstractHerpesviruses are double-stranded DNA viruses occurring at a high prevalence in the human population and are responsible for a wide array of clinical manifestations and diseases, from mild to severe. These viruses are classified in three subfamilies (Alpha-, Beta- and Gammaherpesvirinae), with eight members currently known to infect humans. Importantly, all herpesviruses can establish lifelong latent infections with symptomatic or asymptomatic lytic reactivations. Accumulating evidence suggest that chemical modifications of viral RNA and DNA during the lytic and latent phases of the infections caused by these viruses, are likely to play relevant roles in key aspects of the life cycle of these viruses by modulating and regulating their replication, establishment of latency and evasion of the host antiviral response. Here, we review and discuss current evidence regarding epitranscriptomic and epigenetic modifications of herpesviruses and how these can influence their life cycles. While epitranscriptomic modifications such as m(6)A are the most studied to date and relate to positive effects over the replication of herpesviruses, epigenetic modifications of the viral genome are generally associated with defense mechanisms of the host cells to suppress viral gene transcription. However, herpesviruses can modulate these modifications to their own benefit to persist in the host, undergo latency and sporadically reactivate.es_ES
Patrocinadordc.description.sponsorshipANID-Millennium Science Initiative Program ICN09_016 Millennium Institute on Immunology and Immunotherapy ICN09_016/ICN 2021_045 P09/016-F FONDECYT grant from ANID 1190864 1190156 Regional Government of Antofagasta through the Innovation Fund for Competitiveness FIC-R 2017 30488811-0es_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherMDPIes_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
Sourcedc.sourceMicroorganismses_ES
Keywordsdc.subjectHerpesviruses_ES
Keywordsdc.subjectLatencyes_ES
Keywordsdc.subjectRNA modificationses_ES
Keywordsdc.subjectDNA modificationses_ES
Keywordsdc.subjectm6Aes_ES
Keywordsdc.subject5mCes_ES
Keywordsdc.subjectm5Ces_ES
Keywordsdc.subjectPseudouridinilationes_ES
Keywordsdc.subject2 '-O-mees_ES
Keywordsdc.subjectHistone modificationses_ES
Títulodc.titleRole of epitranscriptomic and epigenetic modifications during the lytic and latent phases of herpesvirus infectionses_ES
Document typedc.typeArtículo de revistaes_ES
dc.description.versiondc.description.versionVersión publicada - versión final del editores_ES
dcterms.accessRightsdcterms.accessRightsAcceso abiertoes_ES
Catalogueruchile.catalogadorapces_ES
Indexationuchile.indexArtículo de publícación WoSes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States